Weetman A P, Yateman M E, Ealey P A, Black C M, Reimer C B, Williams R C, Shine B, Marshall N J
Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.
J Clin Invest. 1990 Sep;86(3):723-7. doi: 10.1172/JCI114768.
To investigate the distribution of thyroid-stimulating antibody (TSAb) activity between IgG subclasses, sera from 11 patients with Graves disease (including the National Institute of Biological Standards and Control (NIBSC) Research Standard, long acting thyroid stimulator-B) were fractionated by chromatography on affinity columns of monoclonal IgG subclass antibodies or protein A to deplete all but a single subclass. The resulting fractions were 98% or more pure for a single subclass. In all 11 patients, TSAb activity appeared to be confined to the IgG1 fraction as determined by cAMP production on addition of the fractions to the FRTL-5 rat thyroid cell line. In all of eight specimens from seven patients so tested, the whole serum activity was recovered in the IgG1 fraction, after adjusting for the recovery of the isotype from the column. TSAb activity in one serum comprised both lambda and kappa light chains but was IgG1 restricted. This IgG subclass restriction was not found when the same fractions were tested for thyroglobulin, microsomal/thyroid peroxidase, or tetanus toxoid antibody activity. Together with previous results showing marked restriction of both light chain usage and isoelectric point of TSAb, these results support the idea that Graves' disease may be the result of an oligo- or possibly monoclonal response at the B cell level.
为研究促甲状腺素抗体(TSAb)活性在IgG亚类之间的分布情况,我们对11例格雷夫斯病患者的血清(包括英国国家生物标准与控制研究所(NIBSC)的研究标准品——长效甲状腺刺激素-B)进行了处理。这些血清通过在单克隆IgG亚类抗体或蛋白A亲和柱上进行层析分离,以去除除单一亚类之外的所有其他成分。得到的各组分单一亚类的纯度达到98%或更高。在所有11例患者中,将各组分添加到FRTL-5大鼠甲状腺细胞系中,通过检测cAMP生成量发现,TSAb活性似乎仅存在于IgG1组分中。在对7例患者的8份标本进行上述检测时,经校正各亚型从柱上的回收率后发现,全部血清活性均在IgG1组分中得以恢复。一份血清中的TSAb活性同时包含λ链和κ链,但仅受限于IgG1。当对相同组分检测甲状腺球蛋白、微粒体/甲状腺过氧化物酶或破伤风类毒素抗体活性时,未发现这种IgG亚类限制现象。结合此前显示TSAb轻链使用情况和等电点均有明显限制的结果,这些结果支持以下观点:格雷夫斯病可能是B细胞水平寡克隆或可能是单克隆反应的结果。